BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 9183179)

  • 1. Pulsed ultrafiltration mass spectrometry: a new method for screening combinatorial libraries.
    van Breemen RB; Huang CR; Nikolic D; Woodbury CP; Zhao YZ; Venton DL
    Anal Chem; 1997 Jun; 69(11):2159-64. PubMed ID: 9183179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advancing Kir4.2 Channel Ligand Identification through Collision-Induced Affinity Selection Mass Spectrometry.
    Gu Y; Liu M; Ma L; Quinn RJ
    ACS Chem Biol; 2024 Mar; 19(3):763-773. PubMed ID: 38449446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of Replication Fork Formation and Progression: Targeting the Replication Initiation and Primosomal Proteins.
    Radford HM; Toft CJ; Sorenson AE; Schaeffer PM
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Collision-Induced Affinity Selection Mass Spectrometry for Identification of Ligands.
    Mak T; Rossjohn J; Littler DR; Liu M; Quinn RJ
    ACS Bio Med Chem Au; 2022 Oct; 2(5):450-455. PubMed ID: 37101899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Native metabolomics identifies the rivulariapeptolide family of protease inhibitors.
    Reher R; Aron AT; Fajtová P; Stincone P; Wagner B; Pérez-Lorente AI; Liu C; Shalom IYB; Bittremieux W; Wang M; Jeong K; Matos-Hernandez ML; Alexander KL; Caro-Diaz EJ; Naman CB; Scanlan JHW; Hochban PMM; Diederich WE; Molina-Santiago C; Romero D; Selim KA; Sass P; Brötz-Oesterhelt H; Hughes CC; Dorrestein PC; O'Donoghue AJ; Gerwick WH; Petras D
    Nat Commun; 2022 Aug; 13(1):4619. PubMed ID: 35941113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A rapid strategy for screening high-efficiency PCSK9 inhibitors from Ginkgo biloba leaves by ligand fishing, HPLC-Q-TOF-MS and interdisciplinary assay.
    Li L; Fan ML; Li YN; Huang YX; Liu XF; Liu JH
    J Food Drug Anal; 2020 Jun; 28(2):273-282. PubMed ID: 35696112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biophysical methods in early drug discovery.
    Holdgate G; Embrey K; Milbradt A; Davies G
    ADMET DMPK; 2019; 7(4):222-241. PubMed ID: 35359617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mega-High-Throughput Screening Platform for the Discovery of Biologically Relevant Sequence-Defined Non-Natural Polymers.
    Avital-Shmilovici M; Liu X; Shaler T; Lowenthal A; Bourbon P; Snider J; Tambo-Ong A; Repellin C; Yniguez K; Sambucetti L; Madrid PB; Collins N
    ACS Cent Sci; 2022 Jan; 8(1):86-101. PubMed ID: 35106376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cannabinoids Block Cellular Entry of SARS-CoV-2 and the Emerging Variants.
    van Breemen RB; Muchiri RN; Bates TA; Weinstein JB; Leier HC; Farley S; Tafesse FG
    J Nat Prod; 2022 Jan; 85(1):176-184. PubMed ID: 35007072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in Magnetic Microbead Affinity Selection Screening: Discovery of Natural Ligands to the SARS-CoV-2 Spike Protein.
    Muchiri RN; Kibitel J; Redick MA; van Breemen RB
    J Am Soc Mass Spectrom; 2022 Jan; 33(1):181-188. PubMed ID: 34939787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug discovery from natural products using affinity selection-mass spectrometry.
    Muchiri RN; van Breemen RB
    Drug Discov Today Technol; 2021 Dec; 40():59-63. PubMed ID: 34916024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a target identification approach using native mass spectrometry.
    Liu M; Van Voorhis WC; Quinn RJ
    Sci Rep; 2021 Jan; 11(1):2387. PubMed ID: 33504855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultra-large chemical libraries for the discovery of high-affinity peptide binders.
    Quartararo AJ; Gates ZP; Somsen BA; Hartrampf N; Ye X; Shimada A; Kajihara Y; Ottmann C; Pentelute BL
    Nat Commun; 2020 Jun; 11(1):3183. PubMed ID: 32576815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Library Screening Strategy Combining the Concepts of MS Binding Assays and Affinity Selection Mass Spectrometry.
    Gabriel J; Höfner G; Wanner KT
    Front Chem; 2019; 7():665. PubMed ID: 31637233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergy and antagonism in natural product extracts: when 1 + 1 does not equal 2.
    Caesar LK; Cech NB
    Nat Prod Rep; 2019 Jun; 36(6):869-888. PubMed ID: 31187844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selection and characterization of botanical natural products for research studies: a NaPDI center recommended approach.
    Kellogg JJ; Paine MF; McCune JS; Oberlies NH; Cech NB
    Nat Prod Rep; 2019 Aug; 36(8):1196-1221. PubMed ID: 30681109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a Magnetic Microbead Affinity Selection Screen (MagMASS) Using Mass Spectrometry for Ligands to the Retinoid X Receptor-α.
    Rush MD; Walker EM; Prehna G; Burton T; van Breemen RB
    J Am Soc Mass Spectrom; 2017 Mar; 28(3):479-485. PubMed ID: 27966173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of analytical techniques for the identification of bioactive compounds from natural products.
    Cieśla Ł; Moaddel R
    Nat Prod Rep; 2016 Oct; 33(10):1131-45. PubMed ID: 27367973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A ligand-observed mass spectrometry approach integrated into the fragment based lead discovery pipeline.
    Chen X; Qin S; Chen S; Li J; Li L; Wang Z; Wang Q; Lin J; Yang C; Shui W
    Sci Rep; 2015 Feb; 5():8361. PubMed ID: 25666181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening a fragment cocktail library using ultrafiltration.
    Shibata S; Zhang Z; Korotkov KV; Delarosa J; Napuli A; Kelley AM; Mueller N; Ross J; Zucker FH; Buckner FS; Merritt EA; Verlinde CL; Van Voorhis WC; Hol WG; Fan E
    Anal Bioanal Chem; 2011 Sep; 401(5):1585-91. PubMed ID: 21750879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.